Levocetirizina Ipca

Levocetirizine Dihydrochloride, the active ingredient in Levocetirizina Ipca, is a second‑generation antihistamine presented as an oral tablet for oral use. It is indicated for the relief of symptoms associated with allergic rhinitis and chronic idiopathic urticaria in adults and children. GNH USA supplies Levocetirizina Ipca as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levocetirizine Dihydrochloride works on histamine‑mediated allergic pathways and is used for the following conditions: - Allergic rhinitis: reduces nasal congestion, itching, sneezing and rhinorrhea. - Chronic idiopathic urticaria: decreases the frequency and severity of hives and itching. - Allergic conjunctivitis: alleviates eye itching, redness and tearing.

Levocetirizine Dihydrochloride is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Drowsiness: mild to moderate sedation, especially at treatment initiation. - Headache: transient, often resolves without intervention. - Dry mouth: reduced salivation during therapy. - Fatigue: feeling of tiredness that may improve over time. - Nausea: occasional stomach upset. - Altered taste: temporary metallic or bitter sensation.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips or tongue requiring urgent care. - Anaphylaxis: severe allergic reaction with respiratory compromise. - Stevens‑Johnson syndrome: rare severe skin eruption. - Tachycardia: rapid heart rate in susceptible individuals. - Hepatic injury: abnormal liver enzymes, monitor if symptoms develop. - Blood dyscrasias: neutropenia or thrombocytopenia, monitor complete blood count if indicated.

Before initiating therapy, consider the following safety measures: - Pregnancy: consult a healthcare professional; risk‑benefit assessment is required. - Renal impairment: dose adjustment may be necessary in moderate to severe dysfunction. - Elderly patients: monitor for increased sedation and falls. - Driving or operating machinery: avoid until individual response to the drug is known. - Concomitant medications: review all drugs for potential interactions. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Levocetirizine Dihydrochloride may interact with several medicines.

Major Interactions (Avoid): - Ketoconazole: can increase levocetirizine plasma concentrations. - Erythromycin: may raise systemic exposure, enhancing side effects. - Ritonavir: potent CYP3A4 inhibitor that can elevate drug levels.

Moderate Interactions (Monitor Closely): - Alcohol: additive central nervous system depression. - Other antihistamines: may increase sedation. - Theophylline: may reduce levocetirizine clearance, requiring observation.